These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Levels of blood theophylline in patients with acute bronchospasm]. Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324 [TBL] [Abstract][Full Text] [Related]
4. Appropriateness of therapeutic drug monitoring for lithium. Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880 [TBL] [Abstract][Full Text] [Related]
5. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV; Nonikov VE; Belousov IuB Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [TBL] [Abstract][Full Text] [Related]
6. Compliance measure development and assessment of theophylline therapy in ambulatory patients. De Tullio PL; Kirking DM; Arslanian C; Olson DE J Clin Pharm Ther; 1987 Feb; 12(1):19-26. PubMed ID: 3449560 [TBL] [Abstract][Full Text] [Related]
7. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
8. Internet-based home monitoring and education of children with asthma is comparable to ideal office-based care: results of a 1-year asthma in-home monitoring trial. Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert M; Malone FJ Pediatrics; 2007 Mar; 119(3):569-78. PubMed ID: 17332210 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of two long-acting theophylline preparations in daily evening administration]. Holzer R Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685 [TBL] [Abstract][Full Text] [Related]
10. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma. Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832 [TBL] [Abstract][Full Text] [Related]
11. Use of troleandomycin as a steroid-sparing agent in both asthma and chronic obstructive pulmonary disease. Shivaram U; Cash M J Assoc Acad Minor Phys; 1991; 2(3):131-3. PubMed ID: 1809456 [TBL] [Abstract][Full Text] [Related]
12. Miocamycin doesn't affect theophylline serum levels in COPD patients. Dal Negro R; Turco P; Pomari C; de Conti F Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):27-9. PubMed ID: 3261281 [TBL] [Abstract][Full Text] [Related]
13. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline. Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of maintenance of therapeutic serum concentrations of theophylline in chronic asthma. Otero MJ; Barrueco M; Mariño E; Gomez F; Dominguez-Gil A Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):157-62. PubMed ID: 3557744 [TBL] [Abstract][Full Text] [Related]
15. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations]. Wiesner B; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957 [TBL] [Abstract][Full Text] [Related]
16. Short-acting versus a long-acting preparation of theophylline ('Xantivent') in the treatment of reversible bronchospasm. Andrasch R; Schmitz-Schumann M Pharmatherapeutica; 1984; 3(10):668-77. PubMed ID: 6463066 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677 [TBL] [Abstract][Full Text] [Related]
18. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764 [TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care. Shelledy DC; Legrand TS; Gardner DD; Peters JI J Asthma; 2009 Mar; 46(2):194-201. PubMed ID: 19253130 [TBL] [Abstract][Full Text] [Related]
20. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion]. Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]